3 Shock&CUB-WHO ppt
-
Upload
aris-maruto -
Category
Documents
-
view
233 -
download
1
description
Transcript of 3 Shock&CUB-WHO ppt
![Page 1: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/1.jpg)
Shock & WHO-CUB
Divisi Fetomaternal, Departemen Obstetri & GinekologiFKUI / RSUPN - CM
![Page 2: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/2.jpg)
QuickTime™ and aYUV420 codec decompressor
are needed to see this picture.
![Page 3: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/3.jpg)
Perdarahan Obstetri
Respirasi
Sirkulasi ( Kegagalan sistem sirkulasi dalam
mempertahankan aliran yang adekuat pada organ-
organ vital sehingga timbul Anoxia)
Trauma
Mengancam jiwa ibu dan janin
![Page 4: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/4.jpg)
Shock
The most common types of shock:
Type of shock Aetiology
Hypovolaemic shock Acute loss of at least 20% of the circulating
volume
Cardiogenic shock Acute disease of the heart, e.g. severe
myocardial infarction
Septic shock Septic condition caused by infectious agents
and their toxic products
Neurogenic shock Head trauma, spinal cord injury
Anaphylactic shock Repeated contact with or injection of
antigenic substances
![Page 5: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/5.jpg)
ShockHemorrhagic Shock – Pathophysiology
Stage 1: Compensated Stage
Mechanism: Volume depletion due to bleeding
Body detects decrease in cardiac output
Sympathetic Nervous System is stimulated releasing Epinephrine and
Norepinehrine to stimulate Alpha and Beta Receptors
Alpha = Vasoconstriction Beta = Bronchodilation and
Cardiac Stimulation
![Page 6: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/6.jpg)
ShockHemorrhagic (Classic) shock –
Pathophysiology
Stage 2: Progressive Stage
Mechanism: Kidneys release anti-diuretic hormone which increases
vasoconstriction by closing the capillary sphincters, greatly reducing
peripheral circulation
Increased hypo-perfusion causes increase in metabolic acid build up
![Page 7: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/7.jpg)
ShockHemorrhagic (Classic) shock – Pathophysiology
Stage 3: Irreversible Stage
Mechanism: Compensatory mechanisms fail
Pre-capillary sphincters open releasing metabolic acids, micro-emboli
and other wastes into circulation
Cell damage, organ failure and death occur
![Page 8: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/8.jpg)
Shock
The Course of Hypovolaemic Shock in Absence of Therapy
Blood Pressure (mm Hg)
Heart rate (min)
Bleeding150
100
50
0Compensation Decompensation Irreversibility
Shock Phases
Heart RateBlood Pressure
(Time)
![Page 9: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/9.jpg)
ShockThe Influence of Volume Replacement on Tissue
Perfusion and Organ Function
Volume Replacement
Cerebral Function
(Body Control)Pulmonary Function
(O2 Supply)
Liver
Function
(metabolism)
Renal Function
(Diuresis)
Heart
Function
(cardiac output)
Tissue
Perfusion
![Page 10: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/10.jpg)
![Page 11: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/11.jpg)
Tata Laksana Mengatasi Perdarahan Hebat
Airway
Breathing
Circulation & hemorrhage control
Shock position
Replace blood loss
Stop / minimize the bleeding process
![Page 12: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/12.jpg)
AIRWAY
![Page 13: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/13.jpg)
Posisi Syok
ANGKAT
KEDUA
TUNGKAI
300 - 500 cc
darah dari kaki
pindah ke
sirkulasi sentral
![Page 14: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/14.jpg)
Tatalaksana Kompresi Bimanual
![Page 15: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/15.jpg)
Menghentikan
Perdarahan Kondom
intra uterin
![Page 16: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/16.jpg)
Menghentikan
Perdarahan Thrombogenic uterine pack
Bobrowski RA, Jones TB. Obstet Gynecol 1995 May;85(5 Pt 2):836-7
Vaginal ligature of uterine arteries
Philippe HJ, d'Oreye D, Lewin D. Int J Gynaecol Obstet 1997 Mar;56(3):267-70
Ligasi a hipogastrika
Histerektomi subtotal
![Page 17: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/17.jpg)
Stepwise uterine
devascularizationAbdRabbo SA Am J Obstet Gynecol 1994 Sep;171(3):694-700
![Page 18: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/18.jpg)
Menghentikan
Perdarahan B-Lynch suture
Dacus JV, Busowski MT, Busowski JD, Smithson S, Masters K, Sibai BM. J Matern Fetal Med 2000 May-Jun;9(3):194-6
Ferguson JE, Bourgeois FJ, Underwood PB. Obstet Gynecol 2000 Jun;95(6 Pt 2):1020-2
![Page 19: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/19.jpg)
Tatalaksana Perdarahan pasca Persalinan
![Page 20: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/20.jpg)
Estimasi BB : ... 60 kg
Estimasi Blood Volume : ... 70 ml/kg x 60 = 4200 ml
Estimasi Blood Loss : .... % EBV = ..... ml
NORMO
VOLEMIA
-- 30% EBV
-- 15%
EBV-- 50%
EBV
TsystNadi
Perf
12080
hangat
100100
pucat
< 90> 120
dingin
< 60-70> 140 -
ttbbasah
EBL = perdarahan 600 1200 2000 ml
Infus RL 1200-2000 2500-5000 4000-8000 ml
![Page 21: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/21.jpg)
Kristaloid vs Koloid Sebagai Cairan PenggantiKristaloid Koloid
Manfaat
Merembes ke komponen
ekstraselular
Mengurangi peningkatan cairan
paru
Meningkatkan fungsi organ
setelah operasi
Reaksi anafilaktik minimal
Kemungkinan dapat mengurangi
angka kematian
Lebih murah
Tetap berada di komponen
intravaskular
volume yang diperlukan
lebih sedikit
Meningkatkan transpor
oksigen ke jaringan,
kontraktilitas jantung dan
keluarannya
ResikoPredisposisi untuk terjadinya
edema pulmonalMahal
Choi et al 1999.
![Page 22: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/22.jpg)
The Clinical Use of BloodWHO Sub – Regional Workshop
![Page 23: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/23.jpg)
![Page 24: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/24.jpg)
![Page 25: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/25.jpg)
![Page 26: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/26.jpg)
![Page 27: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/27.jpg)
![Page 28: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/28.jpg)
![Page 29: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/29.jpg)
Estimating Allowable Blood LoosClinical condition
Healthy Average Poor
Percentage Methode
Acceptabel loss
of blood vol30% 20% 10%
Haemodilution Method
Lowest
Acceptable Hb9 mg / dl 10 mg / dl 11 mg / dl
Lowest
acceptable Ht27% 30% 33%
![Page 30: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/30.jpg)
Blood Loss
% Loss of blood
Volume
Equivalent
Adult fluid
Volume
Replacement
Fliud
< 20 % Up to 1 LiterCrystalloid ( e.g.
0,9 % saline )
> 20 % More than 1 liter
Crystalloid and /
or Colloid
Red Cell
![Page 31: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/31.jpg)
![Page 32: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/32.jpg)
![Page 33: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/33.jpg)
![Page 34: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/34.jpg)
![Page 35: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/35.jpg)
![Page 36: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/36.jpg)
![Page 37: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/37.jpg)
Starting Transfusion Warming of blood is not necessary for routine tx . Warming
increasing metabolism, reduce 2,3-DPG & risk bacterial growth
Indication for warming blood:
Adult receiving over 50 ml/kg/hr
Child receiving over 14 ml/kg/hr
Exchange tranfusion
Rapid infusion CVP lines
Presence of cold aglutinines
![Page 38: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/38.jpg)
Starting Transfusion
Prohibited to addition drugs & medications to blood bag/set EXCEPT normal Saline.
Do not use dextrose 5% or Ringer Lactate.
Use 170 u standard filter.
Transfusion must be completed in 4 hours.
Hemodynamically stable 2 hours
Hemodynamically unstable 4 hours
![Page 39: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/39.jpg)
Autologous Blood
Pre Operative Blood Donation
Min Hb 11 gr
1 Unit ( 10-15% Blood vol) 5-7 days
35 days-2 days, iron suppl
Acute Normovolemic Haemodilution
During surgery ( 4 hours )
Monitoring, Replace fluid : crystaloid 1:3, Colloid 1:1
Blood Salvage
Direct tranfusion
![Page 40: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/40.jpg)
Don’ts for Blood Transfusion
Don’t Use blood from non-licensed.
Don’t delay initiation of blood transfusion.
Don’t Warm blood in an monitored fashion.
Don’t Use routine pre-transfusion medication.
![Page 41: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/41.jpg)
Don’ts for Blood Transfusion
Don’t transfuse over more 4 hours.
Don’t leave patients unmonitored.
Don’t add any medication to blood bag
Don’t forget to return unused blood to blood bank
for disposal
![Page 42: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/42.jpg)
Don’ts for Blood Transfusion
Don’t ask for all the blood bag at one time
Don’t Use unmonitored refrigerator for
storage
Don’t Use one transfusion set for more
than 4 hours / more than 4 unit of blood
Don’t wet outlet port of blood bag while
warming or thawing
![Page 43: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/43.jpg)
Don’ts for Blood Transfusion
Don’t store platelets in a refrigerator
Don’t be complacement while checking identifiying
information
Don’t Use blood from immediate relatives unless
irradiated
![Page 44: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/44.jpg)
Transfusion Reactions
Immediate Delayed
Hemolytic Non-hemolytic
HemolyticTransfusion
Reaction
FebrileAllergic
Hypo-calcemia
Hyper- Kalemia & Acidosis
Acute Lung Injury
Infections Allergic
![Page 45: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/45.jpg)
![Page 46: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/46.jpg)
![Page 47: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/47.jpg)
![Page 48: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/48.jpg)
“Practice Safe Transfusion”
Informed Consent Standardized Guidelines
Adverse EventReporting
Error and IncidentReporting
![Page 49: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/49.jpg)
“Errors can be prevented by designing systems that make it hard for people to do the wrong thing and easy for people to do
the right thing”……
To Error is Human, Building a Safer Health System
![Page 50: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/50.jpg)
Summary
Components
Indications
Transfusion Reactions
![Page 51: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/51.jpg)
Rujukan
ACOG. Hemorrhagic shock. Educational Bulletin #235,
1997.
Choi PT-L et al. 1999. crystalloid vs. colloids in fluid
resuscitation: A systematic review. Critical Care Medicine
27( 1): 200-210.
Scheirhout and Roberts 1998. Fluid resuscitation with
colloid or crystalloid in critically ill patients: A systematic
review of randomized trials. BMJ 316:961-964.
MNH Post Partum Hemorrage.
The Clinical Use of Blood, WHO 2002.
![Page 52: 3 Shock&CUB-WHO ppt](https://reader034.fdocuments.net/reader034/viewer/2022050910/5695d4f81a28ab9b02a3814e/html5/thumbnails/52.jpg)
Terima Kasih